Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Baseline characteristics of participants in the Women's Health Study.

Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE.

J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27.

PMID:
10718501
2.

The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.

Bassuk SS, Albert CM, Cook NR, Zaharris E, MacFadyen JG, Danielson E, Van Denburgh M, Buring JE, Manson JE.

J Womens Health (Larchmt). 2004 Jan-Feb;13(1):99-117.

PMID:
15006283
3.

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):56-65.

PMID:
15998891
5.

Women's health research: evidence from two major trials.

Brandt D.

Am J Nurs. 2005 Nov;105(11):21. No abstract available.

PMID:
16264294
6.

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.

Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH.

J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6.

PMID:
10601381
7.
8.
9.

Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

Bassuk SS, Manson JE, Lee IM, Cook NR, Christen WG, Bubes VY, Gordon DS, Copeland T, Friedenberg G, D'Agostino DM, Ridge CY, MacFadyen JG, Kalan K, Buring JE.

Contemp Clin Trials. 2016 Mar;47:235-43. doi: 10.1016/j.cct.2015.12.022. Epub 2016 Jan 6.

10.

Women's study finds vitamin E, aspirin not so helpful.

[No authors listed]

Harv Womens Health Watch. 2005 Sep;13(1):6. No abstract available.

PMID:
16224840
11.

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):47-55.

PMID:
15998890
12.

A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group.

Manson JE, Gaziano JM, Spelsberg A, Ridker PM, Cook NR, Buring JE, Willett WC, Hennekens CH.

Ann Epidemiol. 1995 Jul;5(4):261-9.

PMID:
8520707
13.

A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.

Pradhan AD, Cook NR, Manson JE, Ridker PM, Buring JE.

Diabetes Care. 2009 Jan;32(1):3-8. doi: 10.2337/dc08-1206. Epub 2008 Oct 3.

14.
15.

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

de Gaetano G; Collaborative Group of the Primary Prevention Project.

Lancet. 2001 Jan 13;357(9250):89-95. Erratum in: Lancet 2001 Apr 7;357(9262):1134.

PMID:
11197445
16.

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2009 Dec;116(12):2386-92. doi: 10.1016/j.ophtha.2009.05.031. Epub 2009 Oct 7.

17.

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.

ASPREE Investigator Group.

Contemp Clin Trials. 2013 Nov;36(2):555-64. doi: 10.1016/j.cct.2013.09.014. Epub 2013 Oct 7.

18.
19.

Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncompliance.

Cook NR, Cole SR, Buring JE.

Eur J Epidemiol. 2012 Jun;27(6):431-8. doi: 10.1007/s10654-012-9702-x. Epub 2012 Jun 15.

20.

[Primary cardiovascular prevention: aspirin, vitamin E or placebo].

Mahé I.

Presse Med. 2001 May 26-Jun 2;30(19):971-2. French. No abstract available.

PMID:
11433732

Supplemental Content

Support Center